Society of Urologic Oncology (SUO)

Saturday, May 16, 2026 1:00 PM to 5:00 PM · 4 hr. (America/New_York)
Ballroom A
Specialty Society
Oncology: General

Information

Learning Objectives:

1. Evaluate potential therapies for patients receiving immunotherapy for advanced bladder.
2. Employ methods of adopting biomarkers into testis cancer management.
3. Present strategies for reducing morbidity and mortality in challenging surgical cases.
4. Analyze controversies in prostate cancer screening, including utilization of biomarkers and imaging, and understanding of screening intensity for average risk and higher risk men.
Of Interest To
Advanced Practice Providers (APP)
Continuing Medical Education
CME

Saturday, May 16

Welcome and Introduction

Saturday, May 16, 2026 1:00 PM to 1:05 PM
Ballroom A

SUO Awards

Saturday, May 16, 2026 1:05 PM to 1:15 PM
Ballroom A
Brian Lane · Corewell Health Medical Group - West
Eric Klein · Cleveland Clinic Foundation

Introduction to the Whitmore Lecture

Saturday, May 16, 2026 1:15 PM to 1:20 PM
Ballroom A

2026 Willet F. Whitmore Jr. Lectureship: Life Lessons Learned

Saturday, May 16, 2026 1:20 PM to 1:40 PM
Ballroom A
Eric Klein · Cleveland Clinic Foundation

Bladder Cancer: Advanced & Systemic Disease, Systemic Therapy & Beyond

Saturday, May 16, 2026 1:40 PM to 2:20 PM
Ballroom A

How to Assess Response After EV-Pembrolizumab?

Saturday, May 16, 2026 1:40 PM to 1:50 PM
Ballroom A

Consolidative Local Therapy After EV-Pembrolizumab Response: Surgery, Radiation, or Surveillance?

Saturday, May 16, 2026 1:50 PM to 2:05 PM
Ballroom A
Kent Mouw · Dana-Farber Cancer Institute

Q&A

Saturday, May 16, 2026 2:05 PM to 2:10 PM
Ballroom A

Three Papers in the Past Year that Influenced My Practice

Saturday, May 16, 2026 2:10 PM to 2:20 PM
Ballroom A

Testis Cancer Biomarkers & Surgical Management of Complex Events

Saturday, May 16, 2026 2:20 PM to 3:05 PM
Ballroom A

Beyond AFP and hCG: Novel Biomarkers Transforming Testis Cancer Management

Saturday, May 16, 2026 2:20 PM to 2:30 PM
Ballroom A

Surgical Management of Complex Scenarios

Saturday, May 16, 2026 2:30 PM to 2:50 PM
Ballroom A

Q&A

Saturday, May 16, 2026 2:50 PM to 2:55 PM
Ballroom A

Three Papers in the Past Year that Influenced My Practice

Saturday, May 16, 2026 2:55 PM to 3:05 PM
Ballroom A

Break

Saturday, May 16, 2026 3:05 PM to 3:20 PM
Ballroom A

Prostate Cancer: Smarter Screening Debate & Panel

Saturday, May 16, 2026 3:20 PM to 4:15 PM
Ballroom A

Prostate Cancer Screening Evidence: Must We Still Do RCTs, or Can We Model?

Saturday, May 16, 2026 3:20 PM to 3:30 PM
Ballroom A

Why Europe Can Still Do RCTs (and What We're Learning)

Saturday, May 16, 2026 3:30 PM to 3:40 PM
Ballroom A

Biomarkers and Advanced Imaging to Inform Screening Practice

Saturday, May 16, 2026 3:40 PM to 3:50 PM
Ballroom A

Panel: Smarter PSA Screening

Saturday, May 16, 2026 3:50 PM to 4:00 PM
Ballroom A

Q&A

Saturday, May 16, 2026 4:00 PM to 4:05 PM
Ballroom A

Three Papers in the Past Year that Influenced My Practice

Saturday, May 16, 2026 4:05 PM to 4:15 PM
Ballroom A
Kendrick Yim · Moffitt Cancer Center

Complementary Medicine in Urologic Oncology

Saturday, May 16, 2026 4:15 PM to 4:25 PM
Ballroom A

First Results from CORE-008 Cohort CX- Study of Intravesical Cretostimogene Grenadenorepvec with Gemcitabine in Patients with High-Risk BCG-Exposed or BCG-Unresponsive Non-Muscle Invasive Bladder Cancer

Saturday, May 16, 2026 4:25 PM to 4:30 PM
Ballroom A

SUO-Clinical Trials Consortium (SUO-CTC) Session

Saturday, May 16, 2026 4:30 PM to 4:55 PM
Ballroom A

SUO-CTC Overview

Saturday, May 16, 2026 4:31 PM to 4:32 PM
Ballroom A

SUO-CTC Membership & Financial Update

Saturday, May 16, 2026 4:32 PM to 4:34 PM
Ballroom A

Bladder Trials Update

Saturday, May 16, 2026 4:34 PM to 4:38 PM
Ballroom A

Prostate Trials Update

Saturday, May 16, 2026 4:38 PM to 4:40 PM
Ballroom A

Renal Trials Update

Saturday, May 16, 2026 4:40 PM to 4:42 PM
Ballroom A

Log in

See all the content and easy-to-use features by logging in or registering!